Clinical trial
Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Reflow Phenomenon in STEMI Patients
NCT06552442 is registered in ClinicalTrials.gov with Amosov National Institute of Cardiovascular Surgery as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Reflow Phenomenon in STEMI Patients
- Lead sponsor
- Amosov National Institute of Cardiovascular Surgery
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 5, 2020
- Completion date
- June 1, 2024
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemia-reperfusion injury, no-reflow